Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
Commentary|Podcasts|February 28, 2025
Selecting the Right 3PL
Author(s)Nicholas Saraceno, Senior Editor
Tracy Lopez uncovers the fundamentals pertaining to third-party logistics providers.
Advertisement
In this exclusive PC Podcast interview, Tracy Lopez, North America’s head of customer service and 3PL operations for Dr. Reddy’s Laboratories, explains:
- How the third-party logistics (3PL) process typically operates
- Key factors manufacturers should take into account when choosing a 3PL, along with the range of services a reliable 3PL should offer
- The important lessons learned since the onset of the COVID-19 pandemic that have contributed to improving operational efficiencies
- Trends within the pharmaceutical industry that 3PLs should be preparing for
- The role of 3PLs in shaping the pharmaceutical industry over the next decade
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Advertisement
Related to this article
Overhaul's Danny Ramon argues that quality and regulatory teams, not just logistics, need faster protocols and more accessible stability data, since stolen or compromised product that re-enters the supply chain through gray markets can ultimately reach patients.
In this week's Pharma Pulse, nine more drugmakers join the MFN program, GoodRx adds a family plan, IPC formalizes its USave partnership, and CSafe expands its thermal cover offerings.
Informa's invitation-only Leadership Summit returns to CPHI Milan Oct. 6 as executives weigh sourcing, medicine security and reshoring pressure.
In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk taps Anthropic for AI-driven drug discovery, and Sanofi, UCB and Opella join AstraZeneca on a supply chain heat decarbonization program.
DSCSA data exchange has matured into daily operations, but the coming NDC-12 shift and a national licensure standard add new work streams before old ones are fully settled.
Gregg Gorniak explains how AI, RFID and serialized data are helping trading partners move DSCSA compliance from a regulatory checkbox to a source of shared operational value.
As HRSA's 340B Rebate Model Pilot moves toward its effective date, Valerie Bandy, PharmD, of Tecsys explains what drug-by-drug rebate tracking really demands from hospital and health system pharmacies.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How Rebate Timing Distorts a Pharmacy's 340B Books
2
EU Pharma Reform: Strategic Implications for US Drugmakers
3
White House Extends MFN Pricing to Every State Medicaid Program
4
Pharma Pulse: Behind the Scenes of LogiPharma USA 2026
5